Theon Pharmaceuticals Limited Roxithromycin Export Data — India (DGFT 2022–2026)

Name: Theon Pharmaceuticals Limited Roxithromycin Export Records India — #10 Exporter, 3 Shipments, $46.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Roxithromycin

India Pharmaceutical Trade Intelligence

$4.2M78 Suppliers30 CountriesHS 30049099

ExportsIndia → VIETNAM33.9%India → CAMBODIA18.3%

ImportsGERMANY → India$752

#1 Supplier: BRAWN LABORATORIES

Theon Pharmaceuticals Limited — Roxithromycin Exporter #10 | $46.9K Trade Value | TransData Nexus | TransData Nexus

Theon Pharmaceuticals Limited — Roxithromycin Exporter Profile

Indian Pharmaceutical Exporter · #10 for Roxithromycin · $46.9K export value · DGFT Verified

Theon Pharmaceuticals Limited is the #10 Indian exporter of Roxithromycin with $46.9K in export value and 3 verified shipments. Theon Pharmaceuticals Limited holds a 1.1% market share in Roxithromycin exports across 1 countries. The company exports 4 pharmaceutical products worth $14.2M across 1 therapeutic categories.

Theon Pharmaceuticals Limited — Roxithromycin Export Profile: Buyers & Destinations

Theon Pharmaceuticals Limited Roxithromycin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Roxithromycin?

Country	Value	Shipments	Share
VIETNAM	$900.0K	18	24.8%
CAMBODIA	$763.2K	68	21.0%
AUSTRALIA	$758.8K	54	20.9%
NEW ZEALAND	$405.4K	10

Who Are the Top Buyers of Roxithromycin from India?

Buyer	Country	Value	Orders
TEVA PHARMA (NEW ZEALAND) LIMITED	NEW ZEALAND	$235.2K	5
MILITARY COMMERICAL JOINT STOCK BANK	VIETNAM	$200.0K	4
APOTEX PTY LTD.,	AUSTRALIA	$182.5K	11
TEVA PHARMA NEW ZEALAND LIMITED	NEW ZEALAND	$170.2K	5
ISKP PHARMA CO., LTD	CAMBODIA	$164.8K	4
HEUMANN PHARMA GMBH CO. GENERICA KG	GERMANY	$159.7K	10
ARROW PHARMACEUTICALS PTY LTD,	AUSTRALIA	$150.2K	10
OPHAM - ROUTE DIGUE ANDRANOAMBO	MADAGASCAR	$129.0K	8
ARROW PHARMACEUTICALS PTY LTD.,	AUSTRALIA	$112.2K	7
CAMEL INTERNATIONAL IM-EXPORT	VIETNAM	$93.2K	3

India's Roxithromycin is purchased by 125 buyers worldwide. The top buyer is TEVA PHARMA (NEW ZEALAND) LIMITED (NEW ZEALAND), followed by MILITARY COMMERICAL JOINT STOCK BANK and APOTEX PTY LTD.,.

How Does Theon Pharmaceuticals Limited Compare to Nearest Roxithromycin Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	MERCURY LABORATORIES LIMITED	$73.2K	5	3	$14.6K
9	CADILA HEALTHCARE LIMITED	$51.2K	13	1	$3.9K
10	THEON PHARMACEUTICALS LIMITED ★	$46.9K	3	1	$15.6K
11	PANGENE BIOTECH LTD	$44.0K	4	1	$11.0K
12	SASHWAT PHARMACEUTICALS PRIVATE LIMITED	$41.0K	11	1	$3.7K

Theon Pharmaceuticals Limited ranks #10 among 78 Indian Roxithromycin exporters. Average shipment value of $15.6K compared to the market average of $36.7K. The closest competitors by value are MERCURY LABORATORIES LIMITED and CADILA HEALTHCARE LIMITED.

Which Indian Ports Ship Roxithromycin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	64	15.0%
SAHAR AIR CARGO ACC (INBOM4)	40	9.4%
SAHAR AIR	35	8.2%
Bombay Air	29	6.8%
NHAVA SHEVA SEA (INNSA1)	25	5.9%
DELHI AIR	24	5.6%
TUGLAKABAD ICD	14	3.3%
BANGALORE ICD	14	3.3%

Geopolitical & Trade Policy Impact on Theon Pharmaceuticals Limited's Roxithromycin Exports

Theon Pharmaceuticals' export operations are currently navigating a complex geopolitical landscape. The escalation of conflicts in the Middle East, particularly the Israel-Iran tensions, has led to disruptions in vital trade corridors. Shipping routes through the Red Sea and the Suez Canal are experiencing increased risks, resulting in longer transit times and higher freight costs. For time-sensitive pharmaceutical shipments, these delays pose significant challenges, especially for temperature-controlled products. According to industry reports, such disruptions could lead to potential losses of approximately $300 million to $600 million for the Indian pharmaceutical industry. (economictimes.indiatimes.com)

In the United States, recent tariff impositions on pharmaceutical imports have introduced additional complexities. Tariffs ranging from 20% to 245% on Chinese pharmaceutical products have prompted U.S. importers to seek alternative sources, potentially benefiting Indian exporters like Theon. However, the U.S. administration's pressure on pharmaceutical companies to lower drug prices and consider reshoring production adds an element of uncertainty. Major pharmaceutical firms have pledged significant investments to expand U.S. operations, which could impact the competitive dynamics for Indian exporters. (lemonde.fr)

The European Union's regulatory landscape is also evolving, with the implementation of the Falsified Medicines Directive (FMD) aimed at preventing counterfeit medicines from entering the supply chain. Compliance with these stringent regulations requires Indian exporters to invest in advanced serialization and tracking systems. For a company like Theon, ensuring adherence to these standards is crucial to maintain access to the lucrative EU market.

Theon Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. Theon Pharmaceuticals must navigate the complex requirements set forth by agencies such as the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Medicines Agency (EMA). Adherence to Good Manufacturing Practices (GMP) is essential to ensure product quality and safety.

Recent developments indicate a tightening of quality compliance measures. The Indian government's Quality Control Orders (QCOs) have expanded significantly, aiming to enhance domestic manufacturing standards and align with global quality benchmarks. While these measures are intended to improve product quality, they also impose additional compliance costs on manufacturers. For Theon, staying abreast of these evolving regulations and investing in compliance infrastructure is critical to sustaining its export operations. (practiceguides.chambers.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Roxithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Theon Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 30+ countries, 125+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Roxithromycin

Roxithromycin

Theon Pharmaceuticals Limited — Roxithromycin Exporter Profile

Theon Pharmaceuticals Limited — Roxithromycin Export Profile: Buyers & Destinations

Where Does India Export Roxithromycin?

Who Are the Top Buyers of Roxithromycin from India?

What Is India's Total Roxithromycin Export Value and How Much Does Theon Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Theon Pharmaceuticals Limited's Roxithromycin Exports?

How Does Theon Pharmaceuticals Limited Compare to Other Indian Roxithromycin Exporters?

Regulatory Requirements: Exporting Roxithromycin to Key Markets

Australia — TGA

How Does Theon Pharmaceuticals Limited Compare to Nearest Roxithromycin Exporters?

Which Indian Ports Ship Roxithromycin Exports?

What Other Advanced Antibiotics Products Does Theon Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Theon Pharmaceuticals Limited's Roxithromycin Exports

Theon Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Theon Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Roxithromycin Export Data from Theon Pharmaceuticals Limited

Roxithromycin Stats

Company Overview

Top Products by Theon Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source